Latest Annual Report News

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

EMU NL has appointed John Anderson as Chair and Adrian Griffin as Managing Director and CEO, marking a significant step in its board renewal process aligned with ASX governance standards.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.

Bank of Queensland reported a 4% increase in revenues to $1.668 billion for FY25, yet profits after tax fell sharply by 53% to $133 million. Despite the profit decline, the bank declared a fully franked 20 cent dividend for the full year.

Regener8 Resources has addressed a sharp doubling in its share price, attributing the surge to growing market interest in its North Achilles project amid soaring silver prices and nearby discoveries.

MedAdvisor Limited will have its trading suspension lifted on 10 October 2025 following the lodgement of its annual financial report, marking a key moment for investors.

Seafarms Group Limited has resumed trading on the ASX following the lifting of its suspension, triggered by the lodgement of its annual financial report.

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

BPH Global Ltd will lift its trading suspension on 2 October 2025 following the lodgement of its annual financial report for the year ended 30 June 2025.